Cytokinetics stock forecast

Author: hvof

August undefined, 2024

WebClose price at the end of the last trading day (Wednesday, 1st Mar 2024) of the CYTK stock was $43.11. This is 0.577% less than the trading day before Tuesday, 28th Feb 2024. During the day the stock fluctuated 2.40% from a day low at $42.86 to a day high of $43.89. WebApr 10, 2024 · It has been a rough year so far for late-stage biopharmaceutical company, Cytokinetics, Incorporated CYTK. Shares of the company have moved down 20.5% compared with the industry’s decline of 4.7%.

CYTK - Cytokinetics Inc Stock Price Quote - NASDAQ

WebStock analysis for Cytokinetics Inc (CYTK:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. WebMar 4, 2024 · The stock price has risen 7.7% to US$36.56 over the past week. ... So while a broad number of companies are forecast to grow, unfortunately Cytokinetics is expected to see its sales affected worse ... early responses to covid-19 in afghanistan

Cytokinetics Gets $450M Long-Term Funding From Royalty Pharma

WebMar 7, 2024 · Cytokinetics, Incorporated's earnings is forecasted to decline at 23.5% and its revenue is expected to decline at 46.6%. Cytokinetics, Incorporated has a predicted … WebApr 6, 2024 · The stock price has decreased by -13.64% in the last 52 weeks. The beta is 0.85, so Cytokinetics's price volatility has been lower than the market average. Beta (1Y) WebMar 20, 2024 · Cytokinetics Stock (NASDAQ:CYTK), Analyst Ratings, Price Targets, Predictions. Analysts publish ratings and price targets on most stocks. csu chancellor search

Cytokinetics, Incorporated (CYTK) Stock Forecasts - Yahoo Finance

Cytokinetics, Incorporated (CYTK) - Stock Analysis

WebApr 2, 2024 · In 2024, Cytokinetics reported revenues of $2.0 million for Q4 and $94.6 million for the full year, compared to $55.6 million and $70.4 million in the same periods … WebApr 10, 2024 · 2. Markets Today: Stock Indexes Fall on Weakness in Tech Stocks. 3. Option Volatility And Earnings Report For April 10 - 14. 4. Despite a Potential Devon Energy Dividend Cut, Investors Short Its Puts for Income. 5. Stocks Set to Open Lower as Investors Await FOMC Minutes, Inflation Data. csu chancellor\u0027s office addressWebApr 2, 2024 · Posted by MarketBeat News on Apr 2nd, 2024. Shares of Cytokinetics, Incorporated ( NASDAQ:CYTK – Get Rating) gapped up before the market opened on Friday . The stock had previously closed at $34 ... early response to dehydration

"WebFeb 28, 2024 · Cytokinetics Stock Up 0.4 %. Shares of CYTK opened at $42.98 on Tuesday. Cytokinetics, Incorporated has a 52 week low of $33.10 and a 52 week high of $55.80. The firm has a market cap of $4.07 billion, a P/E ratio of -13.60 and a beta of 0.90. The firm's 50-day simple moving average is $43.66 and its 200 day simple moving … " - Cytokinetics stock forecast

Cytokinetics stock forecast

Cytokinetics, Incorporated (CYTK) Stock Forecast & Price …

Web2 days ago · The Cytokinetics stock price fell by -3.54% on the last day (Wednesday, 12th Apr 2024) from $35.30 to $34.05. During the last trading day the stock fluctuated 5.99% … WebMar 20, 2024 · The latest price target for . Cytokinetics (NASDAQ: CYTK) was reported by JP Morgan on March 20, 2024.The analyst firm set a price target for $52.00 expecting CYTK to rise to within 12 months (a ...

Did you know?

WebCytokinetics Stock Forecast Over the next 52 weeks, Cytokinetics has on average historically risen by 8.6% based on the past 18 years of stock performance. … WebMar 2, 2024 · Find out the current price target and stock forecast for Cytokinetics ... the average price target for Cytokinetics comes to $61.40. The forecasts range from a low of $47.00 to a high of $80.00 ...

WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Investors & Media Cytokinetics’ unparalleled expertise has kept it at the forefront of drug discovery and development for diseases impacting muscle performance. WebJan 10, 2024 · The average Cytokinetics stock forecast of $55.44 implies 57.7% upside potential from current levels.Bloggers Weigh InTipRanks data shows that financial blogger opinions are 100% Bullish on CYTK ...

WebApr 9, 2024 · Shares of CYTK stock opened at $36.42 on Friday. The stock has a fifty day moving average price of $39.79 and a 200 day moving average price of $42.22. The stock has a market cap of $3.48 billion ... WebCYTK - Cytokinetics Inc Stock quote - CNNMoney.com Markets Tech Media Success Video Cytokinetics Inc (NASDAQ:CYTK) Real-Time Quotes 35.31 BATS BZX Real-Time Price As of 1:28pm ET -0.84 / -2.32%...

WebSOUTH SAN FRANCISCO, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on March 31, 2024 it granted stock …

Web18 hours ago · Price To Free Cash Flow is a widely used stock evaluation measure. Find the latest Price To Free Cash Flow for Cytokinetics (CYTK) ... * Price Target & Stock Forecast ; Full Company Report ... early resorts gunflint trailWeb2 days ago · In 2024, Cytokinetics's revenue was $94.59 million, an increase of 34.30% compared to the previous year's $70.43 million. Losses were -$388.96 million, 80.6% … early responsive to dehydrationWebApr 6, 2024 · Cytokinetics initiated with buy rating, $60 price target at Truist Dec. 20, 2024 at 7:41 a.m. ET by Steve Gelsi Cytokinetics started at buy with $80 stock price target at … early retirement 1995 nhs pension schemeWebApr 10, 2024 · Summary of all time highs, changes and price drops for Cytokinetics; Historical stock prices; Current Share Price: US$34.99: 52 Week High: US$55.80: 52 … early retirement age calculatorWebApr 6, 2024 · Cytokinetics last issued its earnings data on March 1st, 2024. The biopharmaceutical company reported ($1.45) EPS for the quarter, missing the consensus estimate of ($1.22) by $0.23. The firm had revenue of $1.96 million for the quarter, compared to analyst estimates of $7.10 million. Its revenue was down 96.5% on a year … early result pregnancy testsWebApr 3, 2024 · Stock Price Forecast. According to 22 stock analysts, the average 12-month stock price forecast for CYTK stock is $ 63.44 , which predicts an increase of 70.72%. … early retirement 401k withdrawalWebGet the latest Cytokinetics, Inc. (CYTK) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. early retirement and cancer